KEYNOTE-975 study design: a Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinoma

Despite curative-intent treatment, most patients with locally advanced esophageal cancer will experience disease recurrence or locoregional progression, highlighting the need for new therapies. Current guidelines recommend definitive chemoradiotherapy in patients ineligible for surgical resection, b...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Future Oncol
Главные авторы: Shah, Manish A, Bennouna, Jaafar, Doi, Toshihiko, Shen, Lin, Kato, Ken, Adenis, Antoine, Mamon, Harvey J, Moehler, Markus, Fu, Xiaolong, Cho, Byoung Chul, Bordia, Sonal, Bhagia, Pooja, Shih, Chie-Schin, Desai, Anjali, Enzinger, Peter
Формат: Artigo
Язык:Inglês
Опубликовано: Future Medicine Ltd 2021
Предметы:
Clinical Trial Protocol
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7927908/
https://ncbi.nlm.nih.gov/pubmed/33533655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon-2020-0969
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы